Evaluation of the stability and immunogenicity of autoclaved and nonautoclaved preparations of a vaccine against American tegumentary leishmaniasis

Vaccine

Volumn 17, Issue 9-10, 1999, Pages 1179-1185

  De Luca, Paula M ^a   Mayrink, Wilson ^b   Alves, Carlos Roberto ^a   Coutinho, Sergio G ^a   Oliveira, Marcia P ^a   Bertho, Alvaro L ^a   Toledo, Vicente P ^b   Costa, Carlos Alberto ^b   Genaro, Odair ^b   Mendonça, Sergio C F ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

American tegumentary leishmaniasis; Autoclaving; Immunogenicity; Leishmania amazonensis; Stability; Vaccine

Indexed keywords

LEISHMANIA VACCINE;

ADULT; ARTICLE; AUTOCLAVE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG SCREENING; DRUG STABILITY; FEMALE; HELPER CELL; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SKIN LEISHMANIASIS; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANIMALS; ANTIGENS, PROTOZOAN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; MALE; PHENOTYPE; PROTOZOAN VACCINES; SKIN TESTS; STERILIZATION;

EID: 0033525905     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00338-7     Document Type: Article

References (28)

1. Grimaldi G. Jr., Tesh R.B., McMahon-Pratt D. A review of the geographic distribution and epidemiology of leishmaniasis in the New World. Am J Trop Med Hyg. 41:1989;687-725.
2. Lainson R., Shaw J.J. Epidemiology and ecology of leishmaniasis in Latin America. Nature. 273:1978;595-600.
3. Modabber F. Vaccines against leishmaniasis. Ann Trop Med Parasitol. 89(Suppl. 1):1995;83-88.
4. Mayrink W., Da Costa C.A., Magalhães P.A., Melo M.N., Dias M., Oliveira-Lima A., Michalick M.S.M., Williams P. A field trial of a vaccine against American dermal leishmaniasis. Trans R Soc Trop Med Hyg. 73:1979;385-387.
5. Antunes C.M.F., Mayrink W., Magalhães P.A., Costa A., Melo N.M., Dias M., Michalick M.S.M., Williams P., Lima A.O., Vieira J.B.F., Schetini A.P.M. Controlled field trials of a vaccine against American cutaneous leishmaniasis. Int J Epidemiol. 15:1986;572-580.
6. Da Costa C.A., Afonso L.C., Toledo V.P., Guimarães T.M., Nascimento E., Tavares C.A., Mayrink W. Immune responses and protection induced in mice by an industrialized vaccine against American cutaneous leishmaniasis. Parassitologia. 34:1992;45-51.
7. Mendonça S.C.F., De Luca P.M., Mayrink W., Restom T.G., Conceição-Silva F., Da-Cruz A.M., Bertho A.L., Da Costa C.A., Genaro O., Toledo V.P.C.P., Coutinho S.G. Characterization of the human T lymphocyte-mediated immune responses induced by a vaccine against American tegumentary leishmaniasis. Am J Trop Med Hyg. 53:1995;195-201.
8. Badaro R., Pedral-Sampaio D., Jonhson W.D., Reed S. Evaluation of the stability of a soluble intradermal skin test antigen preparation in American visceral leishmaniasis. Trans R Soc Trop Med Hyg. 84:1990;226-227.
9. Da Costa C.A., Toledo V.P.C.P., Genaro O., Williams P., Mayrink W. Montenegro skin test: evaluation of the composition and stability of the antigen preparation. Mem Inst Oswaldo Cruz. 91:1996;193-194.
10. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
11. Niellsen B.L., Brow L.R. The basis for colored silver protein complex formation in stained polyacrilamide gels. Anal Biochem. 141:1984;311-315.
12. Camargo E.P. Growth and differentiation in Trypanosoma cruzi. 1. Origin of metacyclic trypanosomes in liquid media. Rev Inst Med Trop Sao Paulo. 6:1964;13-100.
13. Melo M.N., Mayrink W., Melo C.A., Magalhães P.A., Dias M., Williams P., Araújo F.G., Coelho M.V., Batista M. Padronização do antígeno de Montenegro. Rev Inst Med Trop Sao Paulo. 19:1977;161-164.
14. Peterson G.L. Determination of total protein. Methods Enzymol. 91:1983;95-119.
15. Lainson R, Shaw JJ. Evolution, classification and geographical distribution. In: Peters W, Killick-Kendrick R, editors. The leishmaniases in biology and medicine, vol. 1. London: Academic Press, 1987. p. 1-120.
16. Heinzel F.P., Sadick M.D., Holaday B.J., Coffman R.L., Locksley R. Reciprocal expression of interferon-gamma or interleukin-4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med. 169:1989;59-72.
17. Convit J., Ulrich M., Fernandez C.T., Tapia F.J., Caceres-Dittmar G., Castes M., Rondon A.J. The clinical and immunological spectrum of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 87:1993;444-448.
18. Bomfim G., Nascimento C., Costa J., Carvalho E.M., Barral-Netto M., Barral A. Variation of cytokine patterns related to therapeutic response in diffuse cutaneous leishmaniasis. Exp Parasitol. 84:1996;188-194.
19. + cells associated with cure of human cutaneous leishmaniasis. Infec Immun. 62:1994;2614-2618.
20. Müller I. Role of T cell subsets during the recall of immunological memory to Leishmania major. Eur J Immunol. 22:1992;3063-3069.
21. + T-cell memory determined by clonal burst size. Nature. 369:1994;652-654.
22. Lau L.L., Jamison B.D., Somasundaram T., Ahmed R. Cytotoxic T-cell memory without antigen. Nature. 369:1994;648-652.
23. Tanchot C., Lemonnier F.A., Pérarnau B., Freitas A.A., Rocha B. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science. 276:1997;2057-2062.
24. Kelso A., Glasebrook A.L. Secretion of interleukin-2 macrophage activating factor, interferon and colony-stimulating factor by alloreactive T lymphocyte clones. J Immunol. 132:1984;2984-2991.
25. Jason J., Larned J. Single-cell cytokine profiles in normal humans: comparison of flow cytometry reagents and stimulation protocols. J Immunol Methods. 207:1997;13-22.
26. Fitch F.W., Stack R., Fields P., Lancki D.W., Cronin D.C. Regulation of T lymphocyte subsets. Ciba Found Symp. 195:1995;68-80.
27. + T cells. Infect Immun. 61:1993;3730-3738.
28. + cells. Eur J Immunol. 23:1993;1181-1184.